Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) Shares Outstanding (2020 - 2025)

Stemtech's Shares Outstanding history spans 6 years, with the latest figure at $158.9 million for Q3 2025.

  • For Q3 2025, Shares Outstanding changed N/A year-over-year to $158.9 million; the TTM value through Sep 2025 reached $158.9 million, changed N/A, while the annual FY2024 figure was $135.8 million, 29.31% up from the prior year.
  • Shares Outstanding for Q3 2025 was $158.9 million at Stemtech, up from $142.4 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $158.9 million in Q3 2025 and bottomed at $6.3 million in Q2 2023.
  • The 5-year median for Shares Outstanding is $51.0 million (2022), against an average of $74.5 million.
  • The largest annual shift saw Shares Outstanding grew 12.66% in 2021 before it skyrocketed 8195.49% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $44.7 million in 2021, then rose by 19.6% to $53.4 million in 2022, then soared by 96.45% to $105.0 million in 2023, then increased by 29.31% to $135.8 million in 2024, then grew by 17.04% to $158.9 million in 2025.
  • Per Business Quant, the three most recent readings for STEK's Shares Outstanding are $158.9 million (Q3 2025), $142.4 million (Q2 2025), and $142.4 million (Q1 2025).